乳腺鉬靶聯(lián)合MRI檢查在中老年乳腺癌診斷中的應(yīng)用價(jià)值(1)
[摘要]目的 探討乳腺鉬靶聯(lián)合MRI檢查在中老年乳腺癌診斷中的價(jià)值。方法 選取2017年3月～2018年8月本院收治的60例中老年乳腺腫瘤患者作為研究對(duì)象，所有患者均行乳腺鉬靶及MRI檢查，以病理檢查作為金標(biāo)準(zhǔn)。比較乳腺鉬靶、MRI檢查及乳腺鉬靶聯(lián)合MRI檢查對(duì)乳腺癌檢出的靈敏度、特異度、準(zhǔn)確率。結(jié)果 乳腺鉬靶診斷的靈敏度、特異度、準(zhǔn)確率分別為56.25%、53.57%、55.00%;MRI診斷的靈敏度、特異度、準(zhǔn)確率分別為62.50%、67.86%、65.00%;乳腺鉬靶聯(lián)合MRI檢查的靈敏度、特異度、準(zhǔn)確率分別為84.38%、92.86%、88.33%。乳腺鉬靶聯(lián)合MRI檢查對(duì)乳腺癌檢出的靈敏度、特異度、準(zhǔn)確率均高于單獨(dú)檢查，差異均有統(tǒng)計(jì)學(xué)意義(P<0.05);乳腺鉬靶與MRI單獨(dú)檢查的靈敏度、特異度、準(zhǔn)確率比較，差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05)。結(jié)論 相較于乳腺鉬靶及MRI單獨(dú)檢查，乳腺鉬靶聯(lián)合MRI檢查對(duì)中老年乳腺癌的檢出能力更強(qiáng)，診斷準(zhǔn)確率、靈敏度和特異度更高，值得臨床應(yīng)用推廣。
[關(guān)鍵詞]乳腺鉬靶;MRI;乳腺癌;中老年
[中圖分類號(hào)] R445.2 [文獻(xiàn)標(biāo)識(shí)碼] A [文章編號(hào)] 1674-4721(2020)1(c)-0145-03
[Abstract] Objective To explore the value of mammography combined with MRI in the diagnosis of breast cancer in middle-aged and elderly people. Methods From March 2017 to August 2018， 60 cases of middle-aged and elderly breast tumor patients admitted to our hospital were selected as research objects. All patients underwent mammography and MRI examination， with pathological examination as the gold standard. To compare the sensitivity， specificity and accuracy of mammography， MRI and mammography combined MRI in breast cancer detection. Results The sensitivity， specificity and accuracy of mammography were 56.25%， 53.57% and 55.00% respectively. The sensitivity， specificity and accuracy of MRI diagnosis were 62.50%， 67.86% and 65.00% respectively. The sensitivity， specificity and accuracy of mammography combined with MRI were 84.38%， 92.86% and 88.33% respectively. The sensitivity， specificity and accuracy of mammography combined with MRI in breast cancer detection were higher than those of single examination， and the differences were statistically significant (P<0.05). There were no significant difference in sensitivity， specificity and accuracy between mammography and MRI (P>0.05). Conclusion Compared with mammography and MRI alone， mammography combined with MRI has stronger detection ability， higher diagnostic accuracy， sensitivity and specificity for middle-aged and elderly breast cancer， which is worthy of clinical application and promotion.
[Key words] Mammography; MRI; Breast cancer; Middle-aged and elderly
乳腺癌是女性常見(jiàn)的惡性腫瘤之一，發(fā)病率位居女性惡性腫瘤的第一位[1]，全世界每年約有110萬(wàn)女性被確診為乳腺癌，該病發(fā)病隱匿、臨床表現(xiàn)不明顯，具有較高的誤診率和漏診率[2]，可能會(huì)延誤最佳治療時(shí)機(jī)。乳腺鉬靶是一種X線攝影檢查，是目前診斷乳腺疾病的首選，具有無(wú)創(chuàng)、分辨率高、重復(fù)性好的優(yōu)點(diǎn)，對(duì)乳腺癌的診斷敏感性為82%～89%[3]。但由于X線穿透力較差，對(duì)于高位、深位乳腺癌或致密型乳腺癌診斷效果較差[4]。隨著MRI在臨床上的廣泛應(yīng)用，乳腺癌的診斷正確率得到較大的提升，同時(shí)也為患者制定治療方案提供了基礎(chǔ)。本研究選取本院收治的60例乳腺腫瘤患者為研究對(duì)象，探討乳腺鉬靶聯(lián)合MRI的診斷價(jià)值，以期為臨床選擇合適的診斷方法提供參考，具體報(bào)道如下。, http://www.www.srpcoatings.com(王佳鑫 陳裕展 陳奕雙)
[關(guān)鍵詞]乳腺鉬靶;MRI;乳腺癌;中老年
[中圖分類號(hào)] R445.2 [文獻(xiàn)標(biāo)識(shí)碼] A [文章編號(hào)] 1674-4721(2020)1(c)-0145-03
[Abstract] Objective To explore the value of mammography combined with MRI in the diagnosis of breast cancer in middle-aged and elderly people. Methods From March 2017 to August 2018， 60 cases of middle-aged and elderly breast tumor patients admitted to our hospital were selected as research objects. All patients underwent mammography and MRI examination， with pathological examination as the gold standard. To compare the sensitivity， specificity and accuracy of mammography， MRI and mammography combined MRI in breast cancer detection. Results The sensitivity， specificity and accuracy of mammography were 56.25%， 53.57% and 55.00% respectively. The sensitivity， specificity and accuracy of MRI diagnosis were 62.50%， 67.86% and 65.00% respectively. The sensitivity， specificity and accuracy of mammography combined with MRI were 84.38%， 92.86% and 88.33% respectively. The sensitivity， specificity and accuracy of mammography combined with MRI in breast cancer detection were higher than those of single examination， and the differences were statistically significant (P<0.05). There were no significant difference in sensitivity， specificity and accuracy between mammography and MRI (P>0.05). Conclusion Compared with mammography and MRI alone， mammography combined with MRI has stronger detection ability， higher diagnostic accuracy， sensitivity and specificity for middle-aged and elderly breast cancer， which is worthy of clinical application and promotion.
[Key words] Mammography; MRI; Breast cancer; Middle-aged and elderly
乳腺癌是女性常見(jiàn)的惡性腫瘤之一，發(fā)病率位居女性惡性腫瘤的第一位[1]，全世界每年約有110萬(wàn)女性被確診為乳腺癌，該病發(fā)病隱匿、臨床表現(xiàn)不明顯，具有較高的誤診率和漏診率[2]，可能會(huì)延誤最佳治療時(shí)機(jī)。乳腺鉬靶是一種X線攝影檢查，是目前診斷乳腺疾病的首選，具有無(wú)創(chuàng)、分辨率高、重復(fù)性好的優(yōu)點(diǎn)，對(duì)乳腺癌的診斷敏感性為82%～89%[3]。但由于X線穿透力較差，對(duì)于高位、深位乳腺癌或致密型乳腺癌診斷效果較差[4]。隨著MRI在臨床上的廣泛應(yīng)用，乳腺癌的診斷正確率得到較大的提升，同時(shí)也為患者制定治療方案提供了基礎(chǔ)。本研究選取本院收治的60例乳腺腫瘤患者為研究對(duì)象，探討乳腺鉬靶聯(lián)合MRI的診斷價(jià)值，以期為臨床選擇合適的診斷方法提供參考，具體報(bào)道如下。, http://www.www.srpcoatings.com(王佳鑫 陳裕展 陳奕雙)
參見(jiàn)：首頁(yè) > 醫(yī)療版 > 疾病專題 > 普通外科 > 乳腺癌